โ˜ ๏ธ SYSTEM HUB ยท TOXICOLOGY

Toxicology Conditions (Aโ€“Z)

Evidence-informed overviews for poisoning and overdoseโ€”symptoms, diagnostics, decontamination and escalationโ€”dynamically curated from our medical library. Always follow local protocols and poison centre advice.

0Symptoms
0Conditions
0Procedures
0Tests
0Medications
Medically reviewed by:Dr. Nathalie Guerrero Camilo, MD
Last reviewed: Apr 28, 2026
Last updated: Apr 28, 2026

Understanding clinical toxicology and poisoning

Clinical toxicology covers diagnosis, management and prevention of poisoning and overdose. Assessment integrates exposure history (substance, formulation, route, dose and time), examination pattern (toxidrome), and targeted testsโ€”including serum drug levels only when results change decisions. WHO chemical safety frameworks, nationally designated poison centres and regional protocols (examples: NICE in the United Kingdom, EAPCCT networks in Europe, coordinated poison-centre networks in other regions) inform decontamination, antidote stewardship and enhanced elimination.

Routes (oral, inhalational, dermal, ocular, injection) shape onset and interventions; pharmacokinetics (including formulation delaysโ€”modified-release, transdermal) informs prognosis and observation periods. Supportive care is universalโ€”airway, breathing, circulation, seizure control, correction of hypo-/hyperglycaemia and acidโ€“base disturbancesโ€”alongside substance-specific therapy where evidence supports it.

Nursing overlaps with renal (fluid shifts, extracorporeal therapy where indicated), hepatic (e.g. paracetamol injury pathways), neurological (altered consciousness), cardiorespiratory (rhythm, ventilation), mental health (safeguarding after deliberate overdose), infectious/environmental medicine when exposures overlap outbreaks or contaminants.

Core concepts in poisoning care

Decontamination indications vary internationallyโ€”activated charcoal in narrow windows for adsorbable ingestions when airway protected; eye/skin irrigation after splash exposures; whole-bowel irrigation only when guideline-supported; gastric lavage highly selective early-window scenarios per policy.

Early
POISON CENTRES
Contact for unidentified agents, antidote availability & referral thresholds
6
ROUTES
Oral, inhalational, dermal, ocular, injection, rarely unusual exposures
ABC
FIRST PRINCIPLE
Supportive care precedes specific therapy unless immediate reversal indicated
Nomogram
PARACETAMOL
Risk stratification and antidote timing differ by regional guideline

๐Ÿšจ Toxicology red flags โ€” escalate immediately

  • Airway compromise or refractory hypoventilation (opioids, sedatives, corrosive injury)
  • Haemodynamic collapse or malignant dysrhythmia (sympathomimetics, cardioactive toxins)
  • Recurrent seizures, declining Glasgow Coma Scale, or signs of intracranial catastrophe
  • Suspected toxic alcohol ingestion with metabolic acidosis / elevated osmolar gap patterns when measured locally
  • Paracetamol (acetaminophen) overdose where threshold criteria for antidote are metโ€”timing-critical
  • Caustics, inhalational burns with stridor, or button batteries ingestedโ€”urgent speciality pathways per protocol
๐Ÿ“‹

Rapid Assessment Pathways

๐Ÿ’Š

Opioids / CNS depression

  • Miosis (often), hypoventilation, sedation ladder
  • Naloxone where indicatedโ€”titrate to ventilation
  • Observe prolonged respiratory depression after reversalโ€”half-life mismatch
  • Mixed ingestionsโ€”avoid risky reversal sequences when benzodiazepines/co-ingestants
๐Ÿ”ฅ

Sympathomimetic tox

  • Agitation, tachycardia, hypertension, hyperthermia
  • Benzodiazepines first-line for seizure/agitation; cooling
  • Avoid unopposed beta-blockade after sympathomimetic exposure patterns
  • ECGโ€”ischaemia, prolonged QTโ€”observe escalation criteria
๐ŸŒ™

Anticholinergic pattern

  • Dry flushed skin, mydriasis, urinary retention, delirium
  • Supportive careโ€”avoid unnecessary restraint when intoxicated
  • Physostigmine exceptionally selective settingsโ€”consult poison specialists
  • Rule out alternative diagnoses mimicking pattern
โš—๏ธ

Paracetamol / delayed hepatopathy

  • Reliable time and formulation historyโ€”acute vs staggered exposures per guideline
  • LFTs/INR may lag earlyโ€”follow institution pathway
  • Acetylcysteine where indication thresholds metโ€”regimen per formulary
  • Escalate for hepatic failure patternsโ€”critical care & transplant pathways locally
๐Ÿ”

Toxicology-related symptoms

Explore the signs and symptoms directory for additional published resources.

Browse signs and symptoms

๐Ÿฅ

Toxicology conditions

๐Ÿฉบ

Nursing procedures

Explore the nursing procedures directory for additional published resources.

Browse nursing procedures

๐Ÿ”ฌ

Diagnostic tests

๐Ÿ’Š

Toxicology medications

๐Ÿ”—

Related Body Systems

โ–ถ References & Guidelines
  1. World Health Organization (WHO). Poisoning and chemical safety.
  2. European Association of Poisons Centres and Clinical Toxicologists (EAPCCT). Clinical toxicology resources.
  3. National Institute for Health and Care Excellence (NICE). Guidance (including acute poisoning).
  4. American Association of Poison Control Centers (AAPCC). Poison centre network (United States example).
  5. British Toxicology Society (BTS). Toxicology education.
  6. Centers for Disease Control and Prevention (CDC). Environmental health.

Explore the full Medical Library

Browse all systems, conditions, symptoms, procedures, tests, and medications across the NurseOnShift clinical reference library.

Open Medical Libraryโ†’

Evidence-based nursing education ยท Clinical resources